Astellas and Boehringer Ingelheim Reach Settlement Agreement with Ranbaxy on Flomax Patent Case

TOKYO and RIDGEFIELD, Conn., Nov. 8 Astellas Pharma Inc.and Boehringer Ingelheim Pharmaceuticals, Inc. (a subsidiary of BoehringerIngelheim Corporation) announced today that the two companies have reached asettlement agreement with Ranbaxy to enter into a stipulation of dismissal ofthe pending U.S. litigation with regard to U.S. Patent No. 4,703,063 forFlomax(R) (tamsulosin hydrochloride) capsules, a treatment for the signs andsymptoms of benign prostatic hyperplasia (BPH).

As a result of this settlement, the case will be dismissed withoutprejudice. The settlement of the litigation provides Ranbaxy with theopportunity to launch a generic tamsulosin hydrochloride product on March 2,2010, prior to the expiration of pediatric exclusivity if such is granted bythe FDA. Further terms of the settlement will not be disclosed.For more information, please contact: Kate O'Connor, Communications & Public Relations Boehringer Ingelheim Pharmaceuticals, Inc. Tel: 203-791-6250 Mobile: 917-446-7400 Astellas Pharma Inc. Corporate Communications Tel: +81-3-3244-3201 Fax: +81-3-5201-7473 http://www.astellas.com

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.

Latest Press Release on General News

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...

A 2017 Hyundai Elantra and 760,000 kilometres of life-saving blood donation deliveries

Mr. Tim German's 2017 Hyundai Elantra a.k.a. "Dark Angel," was bought new from Steele Hyundai Halifax and now has more than 760,000 kilometres on the odometer. With his Elantra, Mr....

Philips Respironics Reaches Agreement with US Government on a Consent Decree Creating a Clear Path Forward

April 10, 2024 Philips confirms that further to communicating the main terms of the Philips Respironics consent decree on January 29, 2024, Philips’ subsidiaries Philips Holding USA ...